MF
MFGenie.ai
Sectoral / Thematic

Nippon India Pharma Fund · Direct · Growth

Nippon India Mutual Fund

NAV

₹630.2169

as of 30 Sept 2026

Expense Ratio

0.99%

Viewing Direct · Growth
Compare Fund

Lumpsum returns (CAGR)

1Y
+13.87%
3Y
+17.73%
5Y
+13.58%
Since Inception
+17.37%

SIP returns (XIRR)

1Y
+13.89%
3Y
+12.32%
5Y
+16.60%
Since Inception
+17.08%

Performance Comparison

Sectoral allocation

as of 31 Aug 2026

Each sector links to the mutual funds most exposed to it.

Thinking about Nippon India Pharma Fund · Direct · Growth?

Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.

+91

By submitting, you agree to our Privacy Policy. No spam, ever.

Compare with Similar Funds

ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth

3Y: +20.25%AUM: ₹6,536 Cr

Tata India Pharma and Healthcare Fund · Regular · Growth

3Y: +16.80%AUM: ₹1,359 Cr

Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth

3Y: +18.62%AUM: ₹932 Cr

ITI Pharma and Healthcare Fund · Regular · Growth

3Y: +16.76%AUM: ₹234 Cr
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds

Fund Details

Fund HouseNippon India Mutual Fund
CategorySectoral / Thematic
Launch Date01 Jan 2013
AMFI Code118759
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Exit LoadW.E.F.March 17 2020 10% of the units allotted shall be redeemed without any exit load on or before completion of 12 months from the date of allotment of units. Any redemption in excess of such limit in the ? rst 12 months from the date of allotment shall be subject to the following exit load Redemption of units would be done on First in First out Basis (FIFO): ? 1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units. ? Nil thereafter.

Available transactions

PurchaseSIPRedeemSWPSwitchSTPDemat

Portfolio holdings

as of 31 Aug 2026

portfolio shared with Nippon India Pharma Fund-Growth Plan-Growth Option

Holding% NAV

What this fund does

Nippon India Pharma Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.

About This Fund

Nippon India Pharma Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Nippon India Mutual Fund. The fund has been operational for over 13 years. The current expense ratio is 0.99%.

Invest Online